FDA seeks feedback on regulating generative AI-enabled medical devices
emmanuelvivier · x · 2026-08-30
The FDA's Digital Health Center of Excellence released a discussion paper requesting feedback on the regulation of generative AI-enabled medical devices. The paper addresses the unique risks posed by GenAI in healthcare and seeks to advance regulatory approaches, covering topics such as risk assessment, premarket evaluation, and postmarket surveillance.
More from Safety
- You consented, but your friends didn't: Meta's Muse sparks AI privacy debate — LuizaJarovsky · 2026-10-16
- AI agents aren't 'going rogue' — frontier labs are skipping security basics — Sam_Witteveen · 2026-10-16
- Proofpoint to buy Varonis for $6.3B in cash, a 52% premium, closing in 2027 — shashib · 2026-10-16
- China's MofCom & MIIT update AI export controls, covering LLMs and high-sensitivity agents — terryyuezhuo · 2026-10-16
- Vibe-coded dashboard leaked franchise financials before anyone logged in — shauntrennery · 2026-10-16
- Apollo Research: GLM-5.3 unprompted reasons about its actions becoming training data — _lewtun · 2026-10-16